{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T12:00:26Z","timestamp":1768737626043,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2001,3]]},"DOI":"10.1067\/mai.2001.113080","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T00:19:27Z","timestamp":1027556367000},"page":"526-530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Skin concentrations of H1-receptor antagonists"],"prefix":"10.1067","volume":"107","author":[{"given":"F.Estelle R.","family":"Simons","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norman A.","family":"Silver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochen","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith J.","family":"Simons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mai.2001.113080_bib1","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJM199506293322608","article-title":"Chronic urticaria","volume":"332","author":"Greaves","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1067\/mai.2001.113080_bib2","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1067\/mai.2000.106484","article-title":"Atopic dermatitis: new insights and opportunities for therapeutic intervention","volume":"105","author":"Leung","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2001.113080_bib3","first-page":"477","article-title":"Antihistamines (H1- and H2-receptor antagonists) in skin disease","author":"Simons","year":"2000"},{"key":"10.1067\/mai.2001.113080_bib4","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2222.1997.tb00707.x","article-title":"Histamine is released in the wheal but not flare following challenge of human skin in vivo: a microdialysis study","volume":"27","author":"Petersen","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"10.1067\/mai.2001.113080_bib5","doi-asserted-by":"crossref","first-page":"8003","DOI":"10.1523\/JNEUROSCI.17-20-08003.1997","article-title":"Specific C-receptors for itch in human skin","volume":"17","author":"Schmelz","year":"1997","journal-title":"J Neurosci"},{"issue":"Suppl 3","key":"10.1067\/mai.2001.113080_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1365-2222.1999.00009.x-i1","article-title":"Non-H1-receptor effects of antihistamines","volume":"29","author":"Church","year":"1999","journal-title":"Clin Exp Allergy"},{"key":"10.1067\/mai.2001.113080_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00003088-199936050-00003","article-title":"Clinical pharmacology of new histamine H1-receptor antagonists","volume":"36","author":"Simons","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1067\/mai.2001.113080_bib8","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0091-6749(95)70183-4","article-title":"Quantitation of H1-receptor antagonists in skin and serum","volume":"95","author":"Simons","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2001.113080_bib9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2165\/00003495-200059020-00020","article-title":"Fexofenadine. A review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria","volume":"59","author":"Simpson","year":"2000","journal-title":"Drugs"},{"key":"10.1067\/mai.2001.113080_bib10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/j.1552-4604.1990.tb01871.x","article-title":"Diphenhydramine: pharmacokinetics and pharmacodynamics in elderly adults, young adults, and children","volume":"30","author":"Simons","year":"1990","journal-title":"J Clin Pharmacol"},{"key":"10.1067\/mai.2001.113080_bib11","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1081-1206(10)63061-X","article-title":"Peripheral H1-blockade effect of fexofenadine","volume":"79","author":"Simons","year":"1997","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1067\/mai.2001.113080_bib12","series-title":"Regression, analysis of variance, and experimental designs","first-page":"517","article-title":"Applied linear statistical models","author":"Neter","year":"1993"},{"key":"10.1067\/mai.2001.113080_bib13","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/j.1552-4604.1988.tb05745.x","article-title":"Basic concepts in pharmacodynamic modeling","volume":"28","author":"Schwinghammer","year":"1988","journal-title":"J Clin Pharmacol"},{"key":"10.1067\/mai.2001.113080_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-198106060-00002","article-title":"Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models","volume":"6","author":"Holford","year":"1981","journal-title":"Clin Pharmacokinet"},{"key":"10.1067\/mai.2001.113080_bib15","series-title":"Physicians\u2019 desk reference","year":"2000"},{"key":"10.1067\/mai.2001.113080_bib16","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1034\/j.1398-9995.1999.00038.x","article-title":"Measurement of interstitial cetirizine concentrations in human skin: correlation of drug levels with inhibition of histamine-induced skin responses","volume":"54","author":"Petersen","year":"1999","journal-title":"Allergy"},{"key":"10.1067\/mai.2001.113080_bib17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/09546639809160545","article-title":"Fexofenadine hydrochloride in the treatment of chronic idiopathic urticaria: a placebo-controlled, parallel-group, dose-ranging study","volume":"9","author":"Paul","year":"1998","journal-title":"J Dermatol Treat"},{"key":"10.1067\/mai.2001.113080_bib18","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0091-6749(99)70091-6","article-title":"A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria","volume":"104","author":"Finn","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2001.113080_bib19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1081-1206(10)62515-X","article-title":"Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria","volume":"84","author":"Nelson","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1067\/mai.2001.113080_bib20","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0190-9622(85)70092-8","article-title":"Double-blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria","volume":"12","author":"Greene","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mai.2001.113080_bib21","first-page":"433","article-title":"Controlled trial of H1-antagonists in the treatment of chronic idiopathic urticaria","volume":"67","author":"Sussman","year":"1991","journal-title":"Ann Allergy"},{"key":"10.1067\/mai.2001.113080_bib22","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1177\/106002809302700612","article-title":"Oral agents in the management of urticaria: patient perception of effectiveness and level of satisfaction with treatment","volume":"27","author":"Pontasch","year":"1993","journal-title":"Ann Pharmacother"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674901411699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674901411699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:47:01Z","timestamp":1758775621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674901411699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["S0091674901411699"],"URL":"https:\/\/doi.org\/10.1067\/mai.2001.113080","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2001,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin concentrations of H1-receptor antagonists","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1067\/mai.2001.113080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}